Albany Molecular Research, Inc. Announces the Availability of Online Investor Information.ALBANY, New York--(BUSINESS WIRE)--March 16, 1999--Albany Molecular Research, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : AMRI AMRI Albany Molecular Research (stock symbol) AMRI Advanced Magnetic Research Institute (Mocksville, NC) AMRI Advanced Materials Research Institute AMRI Adult Movie Review Index ), a leader in the outsourcing of chemistry research services to pharmaceutical, biotechnology, and other life sciences companies, today announced the availability of its new investor relations Investor relations The process by which the corporation communicates with its investors. Website, accessible from the Company's existing Website at "http://www.albmolecular.com". The investor relations Website, maintained by Boston, Massachusetts-based CCBN CCBN Central Coast Bancorp CCBN Charles County Business Network , is designed to provide the investment community and the public with comprehensive corporate information. "The addition of an investor relations section to our company Website is an important aspect of our corporate communications program in the wake of our becoming a publicly-traded company last month," said Thomas E. D'Ambra, Ph.D., Chairman and Chief Executive Officer of Albany Molecular Research, Inc. "Our Website has been one of our most important marketing tools over the last few years, and we are adding additional value to our Website as an information resource by making our financial data readily available to investor analysts, shareholders, financial institutions, and even to our customers and the public. From our investor relations Website, people can learn more about our company's management, our performance as a company, access our SEC filings, and keep up with company news by reviewing our recent press releases." "We are delighted that Albany Molecular Research, Inc. has chosen CCBN to help them communicate with the online investment community," said Jeffrey Parker, founder and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of CCBN. "With their online investor relations Website, Albany Molecular Research, Inc. has matched its leading position as a provider of chemistry research services with a leading-edge, Internet-based investor relations program." Albany Molecular Research is an integrated chemistry outsourcing company that offers a broad range of chemistry research and development services to pharmaceutical and biotechnology companies involved in drug discovery and development. The Company offers services traditionally provided by chemistry divisions within pharmaceutical companies, including medicinal chemistry, chemical development, analytical chemistry services and small-scale manufacturing. The Company's objective is to be the leading provider of comprehensive outsourced chemistry research services to the pharmaceutical and biotechnology industries. Albany Molecular Research, Inc. recently completed its initial public offering (IPO (Initial Public Offering) The first time a company offers shares of stock to the public. While not a computer term per se, many founders, employees and insiders of computer companies have found this acronym more exciting than any tech term they ever heard. ) of common stock on February 4, 1999, selling 2,500,000 shares at $20 per share. ING Baring Furman Selz LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control lead-managed the underwriting group for the IPO, with Hambrecht & Quist acting as co-manager. More information about CCBN and its services may be found at its Website, "http://www.ccbn.com". Statements in this press release that are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995 that involve risk and uncertainties. The Company's actual results could differ materially from such forward looking statements. Factors which could cause such difference are discussed under the caption "Risk Factors" in the Company's Final Prospectus Final Prospectus A legal document stating the price of a newly issued security, the delivery date, and other facts that are important for investors. Notes: The final prospectus must be given to every investor who purchases a new issue of registered securities. dated February 4, 1999, as filed with the Securities and Exchange Commission. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion